Back to Search
COLE CHENEY, MD
MD
Pain Medicine (Physical Medicine & Rehabilitation) Physician
NPI: 1922539568IndividualAccepts Medicare
Specialties, Licenses & Credentials
Physical Medicine & Rehabilitation Physician
Physical Medicine & Rehabilitation
Code: 208100000X
10955781-1205(UT)
Pain Medicine (Physical Medicine & Rehabilitation) PhysicianPrimary
Physical Medicine & Rehabilitation — Pain Medicine
Code: 2081P2900X
036155304(IL)71779(MN)
Education
UNIVERSITY OF IOWA, RJ & L CARVER COLLEGE OF MEDICINE
Class of 2017
Clinical Trials (1)
1
Linked Trials
1
Recruiting
0
With Results
Research & Publications (20)
A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma.
PMID 19225537·Leukemia·2009
3-trial
The humanized CD40 antibody SGN-40 demonstrates pre-clinical activity that is enhanced by lenalidomide in chronic lymphocytic leukaemia.
PMID 19183192·Br J Haematol·2009
8-other
A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses.
PMID 19475609·J Med Virol·2009
8-other
The PtdIns 3-kinase/Akt pathway regulates macrophage-mediated ADCC against B cell lymphoma.
PMID 19148288·PLoS One·2009
7-preclinical
Choice of fixative is crucial to successful immunohistochemical detection of phosphoproteins in paraffin-embedded tumor tissues.
PMID 19001637·J Histochem Cytochem·2009
7-preclinical
A novel Raji-Burkitt's lymphoma model for preclinical and mechanistic evaluation of CD52-targeted immunotherapeutic agents.
PMID 18223233·Clin Cancer Res·2008
7-preclinical
IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leukemia cells in vitro.
PMID 18182577·Blood·2008
8-other
Mediation of apoptosis by and antitumor activity of lumiliximab in chronic lymphocytic leukemia cells and CD23+ lymphoma cell lines.
PMID 18032710·Blood·2008
7-preclinical
Rituximab and 17-allylamino-17-demethoxygeldanamycin induce synergistic apoptosis in B-cell chronic lymphocytic leukaemia.
PMID 17949452·Br J Haematol·2007
8-other
Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical.
PMID 17440052·Blood·2007
7-preclinical
Effect of previous locoweed (Astragalus and Oxytropis species) intoxication on conditioned taste aversions in horses and sheep.
PMID 17431041·J Anim Sci·2007
7-preclinical
Mcl-1 is a relevant therapeutic target in acute and chronic lymphoid malignancies: down-regulation enhances rituximab-mediated apoptosis and complement-dependent cytotoxicity.
PMID 17404098·Clin Cancer Res·2007
8-other
Alemtuzumab induces caspase-independent cell death in human chronic lymphocytic leukemia cells through a lipid raft-dependent mechanism.
PMID 16341049·Leukemia·2006
4-observational
Interaction of vestibular, echolocation, and visual modalities guiding flight by the big brown bat, Eptesicus fuscus.
PMID 15156093·J Vestib Res·2004
7-preclinical
Low plasma retinol concentrations increase the risk of developing bronchopulmonary dysplasia and long-term respiratory disability in very-low-birth-weight infants.
PMID 15585773·Am J Clin Nutr·2004
8-other
Modeling hamsters for evaluating West Nile virus therapies.
PMID 15196819·Antiviral Res·2004
7-preclinical
Hu1D10 induces apoptosis concurrent with activation of the AKT survival pathway in human chronic lymphocytic leukemia cells.
PMID 14630799·Blood·2004
8-other
The association between vitamin C and vitamin E supplement use before hematopoietic stem cell transplant and outcomes to two years.
PMID 12891146·J Am Diet Assoc·2003
8-other
Iron deficiency is unacceptably high in refugee children from Burma.
PMID 14652363·J Nutr·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 251 E HURON ST
CHICAGO, IL 60611 - Phone
- (312) 926-2000
Quick Facts
- NPI
- 1922539568
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 3
- Years in Practice
- 9
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile